Latest News and Press Releases
Want to stay updated on the latest news?
-
New patient Customer Acquisition Cost (CAC) decreased 8% sequentially, while new patient acquisitions per day for comparable brands increased 11%Revenue increased to a record $22.3 million, up 145%...
-
- Partnership enables LifeMD to offer best-in-class, personalized medical care by providing providers on the platform a deeper understanding of their patients’ medical histories - NEW YORK, Aug. 04,...
-
NEW YORK, July 26, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD) is a rapidly growing direct-to-patient telehealth company that offers cash pay virtual medical treatment,...
-
NEW YORK, July 15, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, has teamed with the world’s leading provider of laboratory diagnostic...
-
A seasoned industry veteran, Mr. Mironov has led transformational M&A and business development transactions in pharma and healthcare, totaling over $5 billion Shared vision of disrupting...
-
NEW YORK, June 03, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, announced today that it has successfully closed a $15 million...
-
NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a rapidly growing direct-to-patient telehealth company, today announced that management will present at the Capital Peak...
-
NEW YORK, May 28, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, announced today that all shareholder suits filed against the...
-
NEW YORK, May 24, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the appointment of prominent dermatologist and...
-
NEW YORK, May 18, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (“the Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced partnerships with internationally acclaimed...